Stephen Clement

Summary

Affiliation: Georgetown University
Country: USA

Publications

  1. ncbi Actos Now for the prevention of diabetes (ACT NOW) study
    Ralph A DeFronzo
    Texas Diabetes Institute and University of Texas Health Science Center, San Antonio, TX, USA
    BMC Endocr Disord 9:17. 2009
  2. ncbi What are the best options for controlling prandial glycemia?
    Stephen Clement
    Georgetown University Hospital, Division of Endocrinology, Building D, Room 232, 4000 Reservoir Road NW, Washington, DC 20007, USA
    Curr Diab Rep 9:355-9. 2009
  3. ncbi Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2
    Stephen Clement
    Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 2007, USA
    Diabetes Technol Ther 4:459-66. 2002
  4. ncbi Management of diabetes and hyperglycemia in hospitals
    Stephen Clement
    Department of Endocrinology, Georgetown University Hospital, Washington, DC 20007, USA
    Diabetes Care 27:553-91. 2004
  5. ncbi Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial
    Stephen Clement
    Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA
    Metabolism 53:54-8. 2004
  6. ncbi Guidelines for glycemic control
    Stephen Clement
    Georgetown University, Washington, DC, USA
    Clin Cornerstone 6:31-9. 2004
  7. ncbi Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation
    Michelle F Magee
    MedStar Research Institute, Washington Hospital Center, Washington, DC, USA
    Endocr Pract 10:81-8. 2004
  8. ncbi Better glycemic control in the hospital: beneficial and feasible
    Stephen Clement
    Division of Endocrinology, Georgetown University Hospital, Washington, DC 20007, USA
    Cleve Clin J Med 74:111-2, 114-20. 2007
  9. ncbi Algorithms for intravenous insulin delivery
    Susan S Braithwaite
    University of North Carolina, Division of Endocrinology, Chapel Hill, NC 27599 7172, USA
    Curr Diabetes Rev 4:258-68. 2008
  10. ncbi American College of Endocrinology position statement on inpatient diabetes and metabolic control
    Alan J Garber
    Endocr Pract 10:4-9. 2004

Collaborators

Detail Information

Publications12

  1. ncbi Actos Now for the prevention of diabetes (ACT NOW) study
    Ralph A DeFronzo
    Texas Diabetes Institute and University of Texas Health Science Center, San Antonio, TX, USA
    BMC Endocr Disord 9:17. 2009
    ..TRIAL REGISTRATION: clinical trials.gov identifier: NCT00220961...
  2. ncbi What are the best options for controlling prandial glycemia?
    Stephen Clement
    Georgetown University Hospital, Division of Endocrinology, Building D, Room 232, 4000 Reservoir Road NW, Washington, DC 20007, USA
    Curr Diab Rep 9:355-9. 2009
    ....
  3. ncbi Oral insulin product hexyl-insulin monoconjugate 2 (HIM2) in type 1 diabetes mellitus: the glucose stabilization effects of HIM2
    Stephen Clement
    Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 2007, USA
    Diabetes Technol Ther 4:459-66. 2002
    ....
  4. ncbi Management of diabetes and hyperglycemia in hospitals
    Stephen Clement
    Department of Endocrinology, Georgetown University Hospital, Washington, DC 20007, USA
    Diabetes Care 27:553-91. 2004
  5. ncbi Oral modified insulin (HIM2) in patients with type 1 diabetes mellitus: results from a phase I/II clinical trial
    Stephen Clement
    Division of Endocrinology and Metabolism, Georgetown University Medical Center, Washington, DC 20007, USA
    Metabolism 53:54-8. 2004
    ..Further clinical investigation is necessary...
  6. ncbi Guidelines for glycemic control
    Stephen Clement
    Georgetown University, Washington, DC, USA
    Clin Cornerstone 6:31-9. 2004
    ..Progress in our understanding of diabetes and new therapeutic agents will dictate modifications of treatment targets and guidelines, with the goal of making euglycemia achievable for all patients with diabetes...
  7. ncbi Subcutaneous insulin therapy in the hospital setting: issues, concerns, and implementation
    Michelle F Magee
    MedStar Research Institute, Washington Hospital Center, Washington, DC, USA
    Endocr Pract 10:81-8. 2004
    ..Development and implementation of specific strategies for insulin delivery and improved methods for blood glucose monitoring should help to achieve target blood glucose levels safely...
  8. ncbi Better glycemic control in the hospital: beneficial and feasible
    Stephen Clement
    Division of Endocrinology, Georgetown University Hospital, Washington, DC 20007, USA
    Cleve Clin J Med 74:111-2, 114-20. 2007
    ..To manage blood glucose effectively, hospitals need to set up formal programs. Attending physicians, endocrinologists, and nurses need to work as a team. Standardized forms with management guidelines are valuable...
  9. ncbi Algorithms for intravenous insulin delivery
    Susan S Braithwaite
    University of North Carolina, Division of Endocrinology, Chapel Hill, NC 27599 7172, USA
    Curr Diabetes Rev 4:258-68. 2008
    ..It is hoped that hypoglycemia and variability of control will become negligible problems, and that fear of hypoglycemia no longer will deflect investigators and caregivers from providing optimal glycemic management...
  10. ncbi American College of Endocrinology position statement on inpatient diabetes and metabolic control
    Alan J Garber
    Endocr Pract 10:4-9. 2004
  11. ncbi American College of Endocrinology position statement on inpatient diabetes and metabolic control
    Alan J Garber
    Endocr Pract 10:77-82. 2004
  12. ncbi Twenty-four hour action of insulin glargine (Lantus) may be too short for once-daily dosing: a case report
    Stephen Clement
    Diabetes Care 25:1479-80. 2002